Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Carolyn F Deacon
Endocrinology and Metabolism
27
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Glucagon-Like Peptide 1
100%
Dipeptidyl Peptidase IV Inhibitor
98%
Metabolic
51%
Peptide
36%
Gastrointestinal Hormone
36%
Insulinotropic
35%
Antidiabetic Agent
25%
Clearance
22%
Glucose
15%
Drug
11%
Medicine & Life Sciences
Dipeptidyl-Peptidase IV Inhibitors
83%
Glucagon-Like Peptide 1
74%
Dipeptidyl Peptidase 4
56%
Type 2 Diabetes Mellitus
47%
Peptides
40%
Gastrointestinal Hormones
29%
Endocrinology
24%
Drug Design
24%
Hypoglycemic Agents
20%
Blood Glucose
17%
Therapeutics
10%